CRVL

CRVL
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2026 | $239.643M ▲ | $22.277M ▲ | $27.906M ▲ | 11.645% ▲ | $0.54 ▲ | $43.744M ▲ |
| Q1-2026 | $234.711M ▲ | $21.478M ▼ | $27.235M ▲ | 11.604% ▲ | $0.53 ▲ | $42.87M ▲ |
| Q4-2025 | $231.514M ▲ | $24.647M ▲ | $26.419M ▲ | 11.411% ▲ | $0.51 ▲ | $40.921M ▲ |
| Q3-2025 | $227.973M ▲ | $22.058M ▼ | $23.771M ▲ | 10.427% ▼ | $0.46 | $38.297M ▲ |
| Q2-2025 | $224.38M | $22.078M | $23.398M | 10.428% | $0.46 | $36.382M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2026 | $207.453M ▲ | $611.681M ▲ | $248.904M ▼ | $362.777M ▲ |
| Q1-2026 | $202.025M ▲ | $597.448M ▲ | $254.916M ▲ | $342.532M ▲ |
| Q4-2025 | $170.584M ▲ | $545.976M ▲ | $223.989M ▼ | $321.987M ▲ |
| Q3-2025 | $162.944M ▲ | $538.777M ▲ | $237.927M ▲ | $300.85M ▲ |
| Q2-2025 | $138.349M | $518.553M | $235.781M | $282.772M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2026 | $27.906M ▲ | $25.024M ▼ | $-9.753M ▲ | $-9.843M ▼ | $5.428M ▼ | $15.271M ▼ |
| Q1-2026 | $27.235M ▲ | $55.011M ▲ | $-15.463M ▼ | $-8.107M ▼ | $31.441M ▲ | $39.548M ▲ |
| Q4-2025 | $26.419M ▲ | $22.921M ▼ | $-8.661M ▲ | $-6.62M ▲ | $7.64M ▼ | $14.26M ▼ |
| Q3-2025 | $23.771M ▲ | $41.647M ▲ | $-9.535M ▲ | $-7.517M ▼ | $24.595M ▲ | $32.112M ▲ |
| Q2-2025 | $23.398M | $22.308M | $-9.886M | $-5.981M | $6.441M | $12.422M |
Revenue by Products
| Product | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|
Network Solutions Services | $80.00M ▲ | $80.00M ▲ | $90.00M ▲ | $90.00M ▲ |
Patient Management Services | $150.00M ▲ | $150.00M ▲ | $150.00M ▲ | $150.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
CorVel comes across as a financially solid, steadily growing company built around a differentiated technology platform in the workers’ compensation and healthcare cost containment space. Its income statement shows consistent revenue and profit growth, the balance sheet is conservative with ample cash and limited leverage, and cash flows comfortably support both investment and shareholder returns. Competitively, CorVel’s integrated platform, proprietary data, and deep domain expertise give it a real edge, but it operates in a market where large, well-funded players are also leaning into technology. The company’s heavy emphasis on AI and internal software development is both its key strength and its key dependency: long-term success will hinge on maintaining that technological lead and translating it into sustained client value and measured expansion into adjacent markets.
NEWS
November 18, 2025 · 10:44 AM UTC
Sarah Scott Named to Business Insurance's “Women to Watch” List for 2025
Read more
November 11, 2025 · 7:18 AM UTC
CorVel Earns Spot on TIME's America's Growth Leaders 2026 List — the Only Company in Its Industry Recognized
Read more
November 4, 2025 · 6:15 AM UTC
CorVel Announces Revenues and Earnings
Read more
October 21, 2025 · 9:13 AM UTC
CorVel Corporation to Host Live Earnings Release Webcast
Read more
September 10, 2025 · 7:22 AM UTC
Three CorVel Partners Recognized as 2025 Theo Award Winners for Excellence in Workers' Compensation
Read more
About CorVel Corporation
https://www.corvel.comCorVel Corporation provides workers' compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2026 | $239.643M ▲ | $22.277M ▲ | $27.906M ▲ | 11.645% ▲ | $0.54 ▲ | $43.744M ▲ |
| Q1-2026 | $234.711M ▲ | $21.478M ▼ | $27.235M ▲ | 11.604% ▲ | $0.53 ▲ | $42.87M ▲ |
| Q4-2025 | $231.514M ▲ | $24.647M ▲ | $26.419M ▲ | 11.411% ▲ | $0.51 ▲ | $40.921M ▲ |
| Q3-2025 | $227.973M ▲ | $22.058M ▼ | $23.771M ▲ | 10.427% ▼ | $0.46 | $38.297M ▲ |
| Q2-2025 | $224.38M | $22.078M | $23.398M | 10.428% | $0.46 | $36.382M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2026 | $207.453M ▲ | $611.681M ▲ | $248.904M ▼ | $362.777M ▲ |
| Q1-2026 | $202.025M ▲ | $597.448M ▲ | $254.916M ▲ | $342.532M ▲ |
| Q4-2025 | $170.584M ▲ | $545.976M ▲ | $223.989M ▼ | $321.987M ▲ |
| Q3-2025 | $162.944M ▲ | $538.777M ▲ | $237.927M ▲ | $300.85M ▲ |
| Q2-2025 | $138.349M | $518.553M | $235.781M | $282.772M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2026 | $27.906M ▲ | $25.024M ▼ | $-9.753M ▲ | $-9.843M ▼ | $5.428M ▼ | $15.271M ▼ |
| Q1-2026 | $27.235M ▲ | $55.011M ▲ | $-15.463M ▼ | $-8.107M ▼ | $31.441M ▲ | $39.548M ▲ |
| Q4-2025 | $26.419M ▲ | $22.921M ▼ | $-8.661M ▲ | $-6.62M ▲ | $7.64M ▼ | $14.26M ▼ |
| Q3-2025 | $23.771M ▲ | $41.647M ▲ | $-9.535M ▲ | $-7.517M ▼ | $24.595M ▲ | $32.112M ▲ |
| Q2-2025 | $23.398M | $22.308M | $-9.886M | $-5.981M | $6.441M | $12.422M |
Revenue by Products
| Product | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|
Network Solutions Services | $80.00M ▲ | $80.00M ▲ | $90.00M ▲ | $90.00M ▲ |
Patient Management Services | $150.00M ▲ | $150.00M ▲ | $150.00M ▲ | $150.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
CorVel comes across as a financially solid, steadily growing company built around a differentiated technology platform in the workers’ compensation and healthcare cost containment space. Its income statement shows consistent revenue and profit growth, the balance sheet is conservative with ample cash and limited leverage, and cash flows comfortably support both investment and shareholder returns. Competitively, CorVel’s integrated platform, proprietary data, and deep domain expertise give it a real edge, but it operates in a market where large, well-funded players are also leaning into technology. The company’s heavy emphasis on AI and internal software development is both its key strength and its key dependency: long-term success will hinge on maintaining that technological lead and translating it into sustained client value and measured expansion into adjacent markets.
NEWS
November 18, 2025 · 10:44 AM UTC
Sarah Scott Named to Business Insurance's “Women to Watch” List for 2025
Read more
November 11, 2025 · 7:18 AM UTC
CorVel Earns Spot on TIME's America's Growth Leaders 2026 List — the Only Company in Its Industry Recognized
Read more
November 4, 2025 · 6:15 AM UTC
CorVel Announces Revenues and Earnings
Read more
October 21, 2025 · 9:13 AM UTC
CorVel Corporation to Host Live Earnings Release Webcast
Read more
September 10, 2025 · 7:22 AM UTC
Three CorVel Partners Recognized as 2025 Theo Award Winners for Excellence in Workers' Compensation
Read more

CEO
Michael G. Combs
Compensation Summary
(Year 2025)

CEO
Michael G. Combs
Compensation Summary
(Year 2025)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2024-12-26 | Forward | 3:1 |
| 2013-06-27 | Forward | 2:1 |
| 2006-12-11 | Forward | 3:2 |
| 2001-09-04 | Forward | 3:2 |
| 1999-06-15 | Forward | 2:1 |
Ratings Snapshot
Rating : B+
Institutional Ownership

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
5.452M Shares
$398.989M

BLACKROCK, INC.
4.678M Shares
$342.353M

VANGUARD GROUP INC
3.288M Shares
$240.6M

RENAISSANCE TECHNOLOGIES LLC
1.775M Shares
$129.875M

BLACKROCK INC.
1.472M Shares
$107.707M

DIMENSIONAL FUND ADVISORS LP
1.252M Shares
$91.601M

STATE STREET CORP
1.149M Shares
$84.053M

GEODE CAPITAL MANAGEMENT, LLC
899.179K Shares
$65.802M

BLACKROCK FUND ADVISORS
862.194K Shares
$63.095M

BOSTON TRUST WALDEN CORP
529.082K Shares
$38.718M

MORGAN STANLEY
486.668K Shares
$35.614M

THRIVENT FINANCIAL FOR LUTHERANS
458.326K Shares
$33.54M

WELLS FARGO & COMPANY/MN
406.521K Shares
$29.749M

NORTHERN TRUST CORP
397.225K Shares
$29.069M

NORGES BANK
334.869K Shares
$24.506M

BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
320.144K Shares
$23.428M

PRICE T ROWE ASSOCIATES INC /MD/
304.608K Shares
$22.291M

CHARLES SCHWAB INVESTMENT MANAGEMENT INC
281.912K Shares
$20.63M

QUBE RESEARCH & TECHNOLOGIES LTD
236.713K Shares
$17.323M

RAYMOND JAMES FINANCIAL INC
221.07K Shares
$16.178M
Summary
Only Showing The Top 20

